Abstract
The intestinal epithelium has emerged as one of the links between the innate and adaptive immune systems. Novel roles have been elucidated for its participation in antigen uptake and presentation, costimulatory signaling, and intestinal homeostasis. Its concomitant interaction with immune cells and commensal flora demonstrates the epitheliums multifaceted responsibility in protecting against intestinal pathology while maintaining immune competence. Its functional capacity is now more clearly defined in disease states such as celiac disease, Crohns disease, and ulcerative colitis and in maintaining intestinal integrity through toll-like receptor signaling pathways.
Keywords: intestinal epithelial cells, intestinal trefoil factor, dextran sulfate sodium, decay-accelerating factor, antimicrobial peptides, cell surface molecules, chemokines and cytokines
Current Molecular Medicine
Title: Mucosal Epithelium in Health and Disease
Volume: 5 Issue: 6
Author(s): Prashant P. Ponda and Lloyd Mayer
Affiliation:
Keywords: intestinal epithelial cells, intestinal trefoil factor, dextran sulfate sodium, decay-accelerating factor, antimicrobial peptides, cell surface molecules, chemokines and cytokines
Abstract: The intestinal epithelium has emerged as one of the links between the innate and adaptive immune systems. Novel roles have been elucidated for its participation in antigen uptake and presentation, costimulatory signaling, and intestinal homeostasis. Its concomitant interaction with immune cells and commensal flora demonstrates the epitheliums multifaceted responsibility in protecting against intestinal pathology while maintaining immune competence. Its functional capacity is now more clearly defined in disease states such as celiac disease, Crohns disease, and ulcerative colitis and in maintaining intestinal integrity through toll-like receptor signaling pathways.
Export Options
About this article
Cite this article as:
Ponda P. Prashant and Mayer Lloyd, Mucosal Epithelium in Health and Disease, Current Molecular Medicine 2005; 5 (6) . https://dx.doi.org/10.2174/1566524054863933
DOI https://dx.doi.org/10.2174/1566524054863933 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
Current Pharmaceutical Design microRNAs to Monitor Pain-migraine and Drug Treatment
MicroRNA Applications of Molecular Dynamics Simulations in Immunology: A Useful Computational Method in Aiding Vaccine Design
Current Proteomics Animal Models of Lung Fibrosis
Current Respiratory Medicine Reviews Neurological Involvement as the Initial Manifestation in Primary Sjögren's Syndrome - A Case Report
Current Rheumatology Reviews The Roles of Corticotropin Releasing Factor (CRF) in Responses to Emotional Stress: Is CRF Release a Cause or Result of Fear/Anxiety?
CNS & Neurological Disorders - Drug Targets Kawasakis Disease, Acrodynia, and Mercury
Current Medicinal Chemistry Cyanobacterial Polyhydroxyalkanoate Production: Status Quo and Quo Vadis?
Current Biotechnology The Immune System of Cancer Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Autophagy Modulators and Neuroinflammation
Current Medicinal Chemistry Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design NF-κB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway
Current Neurovascular Research Tetherin Antagonism by Primate Lentiviral Nef Proteins
Current HIV Research From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives
Current Clinical Pharmacology Novel Hexahydropyridoindole Derivative as Prospective Agent Against Oxidative Damage in Pancreatic βCells
Medicinal Chemistry Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches
Current Cancer Therapy Reviews 7-prenyloxi-6-methoxycoumarin from Polygala sabulosa A.W. Bennett Regulates p38 MAPK and NF-kB Pathways Inhibiting the Inflammation Induced by Carrageenan in the Mouse Model of Pleurisy
Inflammation & Allergy - Drug Targets (Discontinued)